Outsourced Pharma Webinars
-
Mastering The Complexities Of Gene Therapy Document Writing
5/20/2025
Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.
-
Solving The AOC Puzzle: Strategies For Chemistry, Manufacturing, And Regulatory Success
5/20/2025
Gain valuable insights from industry experts on overcoming the unique chemical, technical, and regulatory challenges of AOC development by watching the recorded webinar.
-
Optimizing Biotherapeutic Protein Expression With CHO Vector Technology
5/19/2025
Review the development of a high-strength synthetic gene promoter that enhances titers while maintaining exceptional product quality and expression stability, to support more efficient biomanufacturing.
-
Combination Products: Navigating Regulatory Strategy, Design Verification
5/19/2025
Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.
-
Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation
5/15/2025
The following insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.
-
Digital Transformation In Contract Manufacturing: A Leadership Perspective
5/13/2025
Discover how PCI Pharma Services embraced digital transformation and gain expert insight on overcoming challenges, driving innovation, and maintaining core values in a regulated industry.
-
Little Patients, Big Challenges: Developing Pediatric Formulations
5/12/2025
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
-
The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials
5/9/2025
Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.
-
PUPSIT Without The Pain: Practical Solutions For Implementation
5/6/2025
Explore the critical role of pre-use post-sterilization integrity testing in quality risk management, as well as learn about integrity testing, wetting procedures, and innovative filtration systems for effective implementation.
-
CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity
4/30/2025
Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.